Nov 12

Disruptive Valve Technology is the future

The 2 year mortality results of PARTNER cohort B are impressive than the one-year results, and this disruptive percutaneous valve technology will change the way elderly patients are treated, said Dr Michael Mack director of cardiovascular surgery for the Baylor Healthcare System in Dallas. TAVI is more effective and less costly.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>